Prudential Jennison Health Sciences Fund

As of the close of business on June 29, 2012, the Fund was closed to new investors. Please see the Fund's prospectus for more detailed information.

Seeks long-term capital appreciation by investing in companies primarily in the drug, healthcare, medicine, medical devices, and biotechnology industries. The Fund may be suited to those seeking the growth potential associated with the healthcare industry and can withstand the volatility associated with sector investing.


 
 

Growth of $10,000

 
 
Past performance does not guarantee future results and current performance may be lower or higher than the past performance data quoted. The investment return and principal value will fluctuate, and shares, when sold, may be worth more or less than the original cost. This chart represents historical performance and does not assume the effects of sales charges. If shown with sales charges, performance would have been lower. It is not possible to invest directly in an index. Click here to view benchmark index definitions.


Morningstar Ratings as of 10/31/2017

      4 stars
Class Q and Z Shares    

Morningstar Overall RatingTM out of 126 Health funds.
Morningstar measures risk-adjusted returns. The overall rating is a weighted average based on the Fund's 3-, 5-, and 10-year star rating.

Portfolio Attributes as of 10/31/2017

Largest Holdings (% of Assets)
UnitedHealth
7.0 %
BioMarin Pharmaceutical
5.4
Humana
4.1
Bluebird Bio
3.6
Incyte
3.6
Aerie Pharmaceuticals
3.5
Allergan
3.5
Cigna
3.5
Illumina
3.1
Aetna
2.7
Top Ten (of 80) 40.0
Geographic Concentration (% of Assets)
United States
93.4 %
Ireland
1.7
United Kingdom
1.3
France
0.7
Italy
0.5
Netherlands
0.4
Israel
0.2
Cash/Equiv
1.8
All data is unaudited and subject to change. Holdings/allocations may vary. This is not a recommendation to buy or sell any security listed. Largest holdings excludes cash, cash equivalents, money market funds and enhanced cash strategies. Totals may not sum due to rounding.


Morningstar Ratings as of 10/31/2017

ClassOverall 3-Year5-Year10-Year
A3 stars
out of 126 funds
2 stars
out of 126 funds
3 stars
out of 118 funds
3 stars
out of 99 funds
B3 stars
out of 126 funds
2 stars
out of 126 funds
3 stars
out of 118 funds
3 stars
out of 99 funds
C3 stars
out of 126 funds
2 stars
out of 126 funds
3 stars
out of 118 funds
3 stars
out of 99 funds
Q4 stars
out of 126 funds
3 stars
out of 126 funds
3 stars
out of 118 funds
4 stars
out of 99 funds
R3 stars
out of 126 funds
2 stars
out of 126 funds
3 stars
out of 118 funds
3 stars
out of 99 funds
Z4 stars
out of 126 funds
3 stars
out of 126 funds
3 stars
out of 118 funds
4 stars
out of 99 funds

Source: Morningstar. The Morningstar Rating may not be calculated based on its share class adjusted historical returns. If so, this investment's independent Morningstar Rating metric uses the fund's oldest share class to determine its hypothetical rating for certain time periods. The Morningstar Rating for funds, or "star rating", is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods. 2017 Morningstar, Inc. All rights reserved. The information contained herein (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance does not guarantee future results.

Key Fund Details

 
ClassFund IDCusipTicker
A055074441P502PHLAX
B055174441P601PHLBX
C037274441P700PHLCX
Q115174441P775PHLQX
R107974441P791PJHRX
Z046374441P866PHSZX
 

 
Fund Statistics
Avg Weighted Market Cap ($mil)
38,508.8
Beta (3 year)
1.52
Standard Deviation (3 year)
21.06
Turnover Ratio (12-month %)
25

 


Prospectus & Shareholder Reports


 
 
The Fund may not be appropriate for all investors. Investing is a specific sector makes the fund nondiversified, thereby increasing its vulnerability to any single economic, political, or regulatory developments, which will have a greater impact on the Fund's return. The Fund may invest in foreign securities, which are subject to currency fluctuation and political uncertainty; short sales, which involve costs and the risk of potentially unlimited losses; and derivative securities, which may carry market, credit, and liquidity risks. These risks may increase the Fund's share price volatility. There is no guarantee the Fund's objective will be achieved.

Average weighted market capitalization is the average market capitalization of stocks in a fund, each weighted by its proportion of assets. Beta measures a fund's sensitivity to changes in the overall market relative to its benchmark. Standard deviation depicts how widely returns vary around its average and is used to understand the range of returns most likely for a given fund. A higher standard deviation generally implies greater volatility. Turnover Ratio is the rate of trading in a portfolio, higher values imply more frequent trading. Beta is benchmarked against the S&P SuperComposite Health Care Index which is an unmanaged capitalization-weighted index that measures the performance of the health care sector of the S&P SC 1500 Index. An investment cannot be made directly in an index. Due to data availability, statistics may not be as of the current reporting period.

Source: Benchmarks and statistics, Lipper Inc. Source of Sector classification: S&P/MSCI (*This figure is comprised of companies that have been classified by S&P/MSCI GICS or classified by Jennison Associates LLC. Companies classified by Jennison Associates LLC are not sponsored by the S&P/MSCI GICS classification system). All other data from PGIM, Inc. (PGIM).

Class Q and Z shares may be available to group retirement plans and institutional investors through certain retirement, mutual fund wrap and asset allocation programs, and to institutions at an investment minimum of $5,000,000. Performance by share class may vary. Other share classes, which contain either a sales load or a contingent deferred sales charge, are also available. These expenses could lower total fund return. Please see the prospectus for additional information about fees, expenses and investor eligibility requirements.

Consider a fund's investment objectives, risks, charges and expenses carefully before investing. The prospectus and summary prospectus contain this and other information about the fund. For more information about a fund, click on the prospectus or summary prospectus link above. Read them carefully before investing.

Mutual funds are distributed by Prudential Investment Management Services LLC and member SIPC. Jennison Associates is a registered investment advisor. Both are Prudential Financial companies. Jennison Associates, Jennison, PGIM and the PGIM logo are service marks of Prudential Financial, Inc. and its related entities, registered in many jurisdictions worldwide.

This material is being provided for informational or educational purposes only and does not take into account the investment objectives or financial situation of any client or prospective clients. The information is not intended as investment advice and is not a recommendation about managing or investing your retirement savings. Clients seeking information regarding their particular investment needs should contact a financial professional.

Mutual funds are not insured by the FDIC or any federal government agency, are not a deposit of or guaranteed by any bank or any bank affiliate, and may lose value.


Prudential Financial, Inc. of the United States is not affiliated with Prudential plc. which is headquartered in the United Kingdom.


0235999-00034-00    Ed. 11/2017

Use the Compare Funds & Benchmarks drop down to add additional Funds and Benchmarks to the chart. All Mountain Chart plot points are on a month end basis. Roll over the chart to view specific details of each month end plot point. The Bar Chart shows the final dollar amount for the investment period and dollar amount chosen.

Compare up to five (5) funds or benchmarks. Reset All
3m6mYTD1y3y5y10yLife
 
 

Past performance does not guarantee future results and current performance may be lower or higher than the past performance data quoted. The investment return and principal value will fluctuate, and shares, when sold, may be worth more or less than the original cost. This chart represents historical performance and does not assume the effects of sales charges. If shown with sales charges, performance would have been lower. Click here to view the most recent Monthly Performance.